Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Vitamin D: Ovarian Cancer - Nutraceuticals World
Research

Vitamin D: Ovarian Cancer

Nutraceutical: Vitamin D

 
Indication: Ovarian cancer
 
Source: Gynecol Oncol, August 2, 2010. [Epub ahead of print]
 
Research: Ecological studies have long described a higher incidence of ovarian cancer in more extreme latitudes, where sun exposure, and presumably vitamin D exposure, is lower. Basic science studies have also noted polymorphisms of the vitamin D receptor in ovarian cancers. The aim of this study was to examine the relationship of serum vitamin D to ovarian cancer. Researchers conducted a case-control study of 7273 subjects using the National Health and Nutrition Examination Surveys (NHANES) database. Serum 25-hydroxyvitamin D (25[OH]D) levels were examined in both ovarian cancer patients and a control population.
 
Results: Ovarian cancer cases were more than three times more likely to have low 25[OH]D levels. Adjusting for significant covariates, which included age and dietary calcium intake, ovarian cancer cases were nearly four times more likely to have low 25[OH]D levels. Researchers believe a deficiency in vitamin D may provide an etiologic link between the long-known ecologic findings regarding latitude and the basic science noting polymorphisms in the vitamin D receptor.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters